PURPOSE
Several reports have implicated nicorandil as a reversible cause of anal ulceration. We have recently commenced a specialist clinic for patients presenting with severe anal ulceration to assess treatment in this difficult group. Recognition of this association may avoid unnecessary surgery.
METHODS
Twenty-six patients treated with nicorandil had severe painful anal ulceration. Examination under anesthesia was required to biopsy the lesions to exclude neoplasia or inflammatory bowel disease. In total, three patients had proximal diverting stomas without subsequent ulcer resolution, two had perineal debridement with one requiring subsequent skin grafting, and one had an abdominoperineal excision for unremitting pain.
RESULTS
The association of perianal ulceration with nicorandil became apparent only in the latter part of this series. Ten ulcers successfully reepithelialized when nicorandil was stopped. Nine patients reported anal pain relief and partial healing on clinical examination at two months but failed to show subsequent complete resolution. One patient agreed to nicorandil cessation and reported symptomatic anal pain relief at two weeks but subsequently developed unstable angina requiring hospital admission. Nicorandil was recommenced with anal pain relapse.
CONCLUSIONS
Failure to recognize nicorandil as an etiologic factor in the development of anal ulceration, when other potential underlying well-recognized inflammatory or neoplastic processes have been excluded, may lead to unnecessary surgical intervention in a group of high-risk patients. One of our patients had a potentially avoidable abdominoperineal resection. Pharmaceutical manipulation with alternative antiangina medication may induce healing. Pharmacologic manipulation should be coordinated with a physician to minimize precipitation of unstable angina.
Similar content being viewed by others
REFERENCES
Prescriptions Pricing Authority NHS. Available at: http://www.ppa.org.uk/news/pact-012001.htm
T Passeron JP Lacour F Mantoux P Fabiani D Dubois JP Ortonne (2004) ArticleTitleChronic anal ulceration due to nicorandil Br J Dermatol 150 394–6 Occurrence Handle1:STN:280:DC%2BD2c7gsFeitw%3D%3D Occurrence Handle14996132
Vella M, Molloy RG. Nicorandil-associated anal ulceration. Lancet 2002;360:1979
M Katory B Davies R Arasaradnam et al. (2004) ArticleTitleNicorandil associated anal ulceration Colorect Dis 6 527 Occurrence Handle1:STN:280:DC%2BD2crltVKnsA%3D%3D
A Watson S Suttie A Fraser T O’Kelly M Loudon (2004) ArticleTitleNicorandil associated anal ulceration Colorect Dis 6 330–1 Occurrence Handle1:STN:280:DC%2BD2cvjtVGkug%3D%3D
A Frydman (1992) ArticleTitlePharmacokinetic profile of nicorandil in humans: an overview J Cardiovasc Pharmacol 20 S34–44 Occurrence Handle1:CAS:528:DyaK38Xmt1GlsLg%3D
A Watson O Al-Ozairi A Fraser M Loudon T O’Kelly (2002) ArticleTitleNicorandil associated anal ulceration Lancet 360 546–7 Occurrence Handle1:CAS:528:DC%2BD38Xmtlels74%3D Occurrence Handle12241662
B Klosterhalfen P Vogel H Rixen C Mittermayer (1989) ArticleTitleTopography of the inferior rectal artery: a possible cause of chronic, primary anal fissure Dis Colon Rectum 32 43–52 Occurrence Handle1:STN:280:BiaD1M%2FnsFI%3D Occurrence Handle2910660
WR Schouten JW Briel JJ Auwerda (1994) ArticleTitleRelationship between anal pressure and anodermal blood flow: the vascular pathogenesis of anal fissures Dis Colon Rectum 37 664–9 Occurrence Handle1:STN:280:ByuB1MfktFE%3D Occurrence Handle8026232
S Agbo-Godeau P Joly P Lauret R Szpirglas H Szpirglas (1998) ArticleTitleAssociation of major aphthous ulcers and nicorandil Lancet 352 1598–9 Occurrence Handle1:STN:280:DyaK1M%2Flslantw%3D%3D Occurrence Handle9843111
F Desruelles P Bahadoran JP Lacour C Perrin J Santini JP Ortonne (1998) ArticleTitleGiant oral aphthous ulcers induced by nicorandil Br J Dermatol 138 712–3 Occurrence Handle1:STN:280:DyaK1czgsVGksQ%3D%3D Occurrence Handle9640391
C Marquart-Elbaz D Lipsker E Grosshans B Cribier (1999) ArticleTitleOral ulcers induced by nicorandil: prevalence and clinicopathological aspects [in French] Ann Dermatol Venereol 126 587–90 Occurrence Handle1:STN:280:DyaK1MvlvF2isQ%3D%3D Occurrence Handle10530345
CM Healy Y Smyth SR Flint (2004) ArticleTitlePersistent nicorandil induced oral ulceration Heart 90 e38 Occurrence Handle1:STN:280:DC%2BD2c3pvFynsg%3D%3D Occurrence Handle15201264
S Reichert A Antunes P Tréchot A Barbaud M Weber J-L Schmutz (1997) ArticleTitleMajor aphthous stomatitis induced by Nicorandil Eur J Dermatol 7 132–3
DM Yellon GF Baxter MS Marber (1996) ArticleTitleAngina reassessed: pain or protector? Lancet 347 1159–62 Occurrence Handle1:STN:280:BymC1MfjvVw%3D Occurrence Handle8609753
JR Parratt KA Kane (1994) ArticleTitleKATP channels in ischaemic preconditioning Cardiovasc Res 28 783–7 Occurrence Handle1:CAS:528:DyaK2cXlslKht7Y%3D Occurrence Handle7923280
JA Auchampach GJ Gross (1993) ArticleTitleAnti-ischaemic actions of potassium channel openers in experimental myocardial is-chaemia/reperfusion injury in dogs Eur Heart J 14 10–5 Occurrence Handle1:CAS:528:DyaK2cXht1Cmt7o%3D
JA Auchampach I Cavero GJ Gross (1992) ArticleTitleNicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels J Cardiovasc Pharmacol 20 765–71 Occurrence Handle1:CAS:528:DyaK3sXhs1Sntw%3D%3D Occurrence Handle1280739
InstitutionalAuthorNameIona Study group (2002) ArticleTitleEffect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial Lancet 359 1269–75
J Yang JD Adams SuffixJr (2004) ArticleTitleStructure activity relationships for nicotinamide in the treatment of stroke Lett Drug Design Discovery 1 58–65 Occurrence Handle1:CAS:528:DC%2BD2cXjvVejt7g%3D
Author information
Authors and Affiliations
Additional information
Reprints are not available.
About this article
Cite this article
Katory, M., Davies, B., Kelty, C. et al. Nicorandil and Idiopathic Anal Ulceration. Dis Colon Rectum 48, 1442–1446 (2005). https://doi.org/10.1007/s10350-005-0027-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-005-0027-7